Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition

May 1, 2008
250 Pages - Pub ID: KLI1646603
Abstract Table of Contents Search Inside Report Related Reports

2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent protection for many drug product. And there is also pressure to reduce the time spent in drug discovery and to bring drugs to market sooner, as well as the ever-present cost considerations.

Kalorama Information's Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail. The report also provides profiles of 23 suppliers, representative of those active in this market.

Segments covered in this report include:

  • Chemistry Services
    • Building Blocks
    • Compound Synthesis
    • Libraries
    • Process Research
    • Other Services

  • Biology Services
    • Protein Expression
    • Structural Analysis
    • Target Validation
    • Pathways Analysis
    • Other Services

  • Screening Services
    • Assay Development
    • Primary Screening
    • Secondary Screening

  • Lead Optimization
    • Early ADMET
    • Analogues Creation
    • Computational Support
    • Other services

In addition to market data and forecasts, the report covers issues such as:

  • What factors should a client consider when deciding whether to do a project in-house or outsource it?
  • Is it in the client's best interest to seek a domestic outsourcing partner, or go with an overseas supplier?
  • How does the client select the CRO that is best for him?
  • What are the best practices when working with a CRO?
  • How do you measure his effectiveness?
  • How do you avoid problems with your CRO?
  • How do you maximize benefits?

This report looks offshore at outsourcing suppliers based in three major areas: India, China, and Eastern Europe. The relative advantages each country provides are contrasted with some of their limitations. The report asses which projects are moving to which suppliers and why.

Related Reports:

Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Aug 1, 2010 - KLI2684026 - $3,995.00

World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
Jul 1, 2010 - KLI2691449 - $4,500.00

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition
Jun 1, 2010 - KLI2605176 - $3,995.00

The Worldwide Over-the-Counter (OTC) Drug Market
May 1, 2010 - KLI2661910 - $3,995.00

The Global Market for RFID in Healthcare
May 1, 2010 - KLI2644911 - $3,995.00

H1N1 "Swine Flu" Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)
May 1, 2010 - KLI2651343 - $1,200.00

The World Anesthesia Drug Market
Apr 1, 2010 - KLI2614802 - $3,995.00

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Oct 1, 2009 - KLI2435380 - $3,500.00

The World Market for Biosimilars and the Potential for US Follow-on Biologics
Aug 1, 2009 - KLI2402283 - $3,700.00

Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Jun 1, 2009 - KLI2155319 - $3,995.00

800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >

Most Popular Research
World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)
Clinical Nutrition Products: World Markets, 3rd Edition
What's Next in Vaccines? HIV, Malaria, MRSA, and 30 Other Vaccine Targets in the 2010-2016 Pipeline
The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Copyright © 2010 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: Monday - Thursday: 3:00am - 7:00pm EST
Fridays: 3:00am - 6:00pm EST